• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Glob Health . Global maternal mortality associated with SARS-CoV-2 infection: a systematic review and meta-analysis

tetano

Editor, Senior Moderator
BMJ Glob Health


. 2025 Apr 21;10(4):e015815.
doi: 10.1136/bmjgh-2024-015815. Global maternal mortality associated with SARS-CoV-2 infection: a systematic review and meta-analysis

Kathryn Barry[SUP] 1 [/SUP], Silvia Fernández-García[SUP] 2 [/SUP], Alya Khashaba[SUP] 1 [/SUP], Gabriel Ruiz-Calvo[SUP] 3 [/SUP], Miriam Roncal Redin[SUP] 4 [/SUP], Ghadir Mahmoud[SUP] 1 [/SUP], Magnus Yap[SUP] 1 [/SUP], Yasmin King[SUP] 5 [/SUP], Dengyi Zhou[SUP] 1 [/SUP], Massa Mamey[SUP] 1 [/SUP], Isabella Shepherd-Evans[SUP] 1 [/SUP], Jameela Sheikh[SUP] 1 [/SUP], Heidi Lawson[SUP] 1 [/SUP], Tania Kew[SUP] 1 [/SUP], Kehkashan Ansari[SUP] 1 [/SUP], Shruti Attarde[SUP] 1 [/SUP], Adeolu Banjoko[SUP] 1 [/SUP], Helen Fraser[SUP] 1 [/SUP], Megan Littmoden[SUP] 1 [/SUP], Tanisha Rajah[SUP] 1 [/SUP], Kate Walker[SUP] 5 [/SUP], Keelin O'Donoghue[SUP] 6 [/SUP], Madelon van Wely[SUP] 7 [/SUP], Elizabeth van Leeuwen[SUP] 8 [/SUP], Elena Kostova[SUP] 7 [/SUP], Heinke Kunst[SUP] 9 10 [/SUP], Asma Khalil[SUP] 11 [/SUP], Vanessa Brizuela[SUP] 12 [/SUP], Edna Kara[SUP] 12 [/SUP], Caron Rahn Kim[SUP] 12 [/SUP], Anna Thorson[SUP] 12 [/SUP], Olufemi T Oladapo[SUP] 12 [/SUP], Lynne Mofenson[SUP] 13 [/SUP], Mercedes Bonet[SUP] 12 [/SUP], Javier Zamora[SUP] 3 14 [/SUP], John Allotey[SUP] 15 16 [/SUP], Shakila Thangaratinam[SUP] 17 18 19 [/SUP]; PregCOV-19 Living Systematic Review Consortium



Collaborators, Affiliations
Abstract

Background: Pregnant and recently pregnant women infected with SARS-CoV-2 are at increased risk of death and serious complications than those without the infection. The extent of variation in mortality rates in pregnant women with SARS-CoV-2 infection across regions, and the causes of death are not known. We systematically reviewed all available evidence on the variation in mortality rates in pregnant women with SARS-CoV-2 infection across geographical and country income groups, and the reported cause of death.
Methods: We searched major databases (December 2019-January 2023) including Medline, LILACS, BIREME and Embase. We included studies that reported deaths in at least 10 consecutive pregnant or recently pregnant women with confirmed SARS-CoV-2 infection and assessed the studies' risk of bias. We calculated the summary estimates of any cause of death as proportions with 95% CIs using a multilevel random-effects logistic regression model. Subgroup analyses were performed by geographical region and country income groups. We used International Statistical Classification of Diseases and Related Health Problems-Maternal Mortality to categorise the reported cause of death.
Findings: From 1 326 315 citations, we included 169 studies (319 172 women with confirmed SARS-CoV-2 infection; 4253 women died). The overall rate of unspecified maternal death was 0.87% (95% CI 0.64% to 1.16%). There were significant differences between geographical regions in rates of maternal mortality, with the highest rates in Sub-Saharan Africa (3.48%; 95% CI 0.66% to 16.42%) and Latin America and the Caribbean (3.16%, 95% CI 1.53% to 6.43%). Rates of maternal mortality varied by country income groups, with the highest rates in low-income countries (4.66%, 95% CI 0.75% to 24.07%). Among women with reported cause of death, 98.6% (2,390/2,423) of deaths were attributable to COVID-19.
Interpretation: Rates of deaths in pregnant and recently pregnant women with SARS-CoV-2 infection vary significantly across regions and by country income groups, with the highest burden in Sub-Saharan Africa and low-income countries. COVID-19 is the main reported cause of death.
Prospero registration number: CRD42020224120.

Keywords: Maternal health; SARS.

 
Back
Top Bottom